Cargando…

216 An Example for Establishing a Clinically Translational Innovation Lab at a University Setting

OBJECTIVES/GOALS: This poster shares a case study on how a group at The Johns Hopkins University formed a translational lab missioned to reinvent currently existing treatments for acute spinal cord injuries, implanting in humans within a five-year window. The poster showcases how a project funded by...

Descripción completa

Detalles Bibliográficos
Autores principales: Kerensky, Max, Doloff, Joshua C, Thakor, Nitish, Theodore, Nicholas, Manbachi, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209215/
http://dx.doi.org/10.1017/cts.2022.118
_version_ 1784729898411098112
author Kerensky, Max
Doloff, Joshua C
Thakor, Nitish
Theodore, Nicholas
Manbachi, Amir
author_facet Kerensky, Max
Doloff, Joshua C
Thakor, Nitish
Theodore, Nicholas
Manbachi, Amir
author_sort Kerensky, Max
collection PubMed
description OBJECTIVES/GOALS: This poster shares a case study on how a group at The Johns Hopkins University formed a translational lab missioned to reinvent currently existing treatments for acute spinal cord injuries, implanting in humans within a five-year window. The poster showcases how a project funded by the Defense Advanced Research Projects Agency has been implemented. METHODS/STUDY POPULATION: The translational team; Holistic Electrical; ultrasonic and Physiological Interventions Unburdening those with Spinal cord injury• (HEPIUS) Lab is composed of many parts as listed below: neurosurgeons; engineers; radiologists; public health specialists; statisticians; patient advocates; ethicists; sonographers; researchers; academic collaborators; and specialized industry partners. Sometimes physically separated; the team has videoconferencing carts across locations to stay connected at every step in the process. The lab facilities were organized with several key facets in mind: research and development (R&D); prototyping; fabrication; verification; and validation (V&V); animal model testing; cadaveric testing accessibility; mock operating room for simulations; and collaboration hubs. RESULTS/ANTICIPATED RESULTS: Due to communications with the US Food and Drug Administration (FDA), DARPA, patient advocates, ethicists, internal review boards, and other bodies, the team has a clear path towards clinical translation. The team has the following stages in progress or scheduled: manufacturing devices, benchtop testing, rat and pig models, biocompatibility testing, cadaveric testing, and clinical use. The lab space was designed to achieve these core functions. For rapid, in-house manufacturing, the lab has unique capabilities including 3D metal printing. For experiments, industry collaborations and equipment acquisitions enable the highest quality research. These technologies are assembled into diagnostic, therapeutic, testing, and manufacturing hubs to drive real change in the lives of many; the patient comes first. DISCUSSION/SIGNIFICANCE: This laboratory, team, and system of operation is aimed to enable novel practices for the clinical translation of spinal cord medical solutions. For researchers interested in launching their own translational work, this poster may serve as a reference, example, and inspiration for similar hopeful university-centered hubs.
format Online
Article
Text
id pubmed-9209215
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-92092152022-07-01 216 An Example for Establishing a Clinically Translational Innovation Lab at a University Setting Kerensky, Max Doloff, Joshua C Thakor, Nitish Theodore, Nicholas Manbachi, Amir J Clin Transl Sci Education OBJECTIVES/GOALS: This poster shares a case study on how a group at The Johns Hopkins University formed a translational lab missioned to reinvent currently existing treatments for acute spinal cord injuries, implanting in humans within a five-year window. The poster showcases how a project funded by the Defense Advanced Research Projects Agency has been implemented. METHODS/STUDY POPULATION: The translational team; Holistic Electrical; ultrasonic and Physiological Interventions Unburdening those with Spinal cord injury• (HEPIUS) Lab is composed of many parts as listed below: neurosurgeons; engineers; radiologists; public health specialists; statisticians; patient advocates; ethicists; sonographers; researchers; academic collaborators; and specialized industry partners. Sometimes physically separated; the team has videoconferencing carts across locations to stay connected at every step in the process. The lab facilities were organized with several key facets in mind: research and development (R&D); prototyping; fabrication; verification; and validation (V&V); animal model testing; cadaveric testing accessibility; mock operating room for simulations; and collaboration hubs. RESULTS/ANTICIPATED RESULTS: Due to communications with the US Food and Drug Administration (FDA), DARPA, patient advocates, ethicists, internal review boards, and other bodies, the team has a clear path towards clinical translation. The team has the following stages in progress or scheduled: manufacturing devices, benchtop testing, rat and pig models, biocompatibility testing, cadaveric testing, and clinical use. The lab space was designed to achieve these core functions. For rapid, in-house manufacturing, the lab has unique capabilities including 3D metal printing. For experiments, industry collaborations and equipment acquisitions enable the highest quality research. These technologies are assembled into diagnostic, therapeutic, testing, and manufacturing hubs to drive real change in the lives of many; the patient comes first. DISCUSSION/SIGNIFICANCE: This laboratory, team, and system of operation is aimed to enable novel practices for the clinical translation of spinal cord medical solutions. For researchers interested in launching their own translational work, this poster may serve as a reference, example, and inspiration for similar hopeful university-centered hubs. Cambridge University Press 2022-04-19 /pmc/articles/PMC9209215/ http://dx.doi.org/10.1017/cts.2022.118 Text en © The Association for Clinical and Translational Science 2022 https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
spellingShingle Education
Kerensky, Max
Doloff, Joshua C
Thakor, Nitish
Theodore, Nicholas
Manbachi, Amir
216 An Example for Establishing a Clinically Translational Innovation Lab at a University Setting
title 216 An Example for Establishing a Clinically Translational Innovation Lab at a University Setting
title_full 216 An Example for Establishing a Clinically Translational Innovation Lab at a University Setting
title_fullStr 216 An Example for Establishing a Clinically Translational Innovation Lab at a University Setting
title_full_unstemmed 216 An Example for Establishing a Clinically Translational Innovation Lab at a University Setting
title_short 216 An Example for Establishing a Clinically Translational Innovation Lab at a University Setting
title_sort 216 an example for establishing a clinically translational innovation lab at a university setting
topic Education
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9209215/
http://dx.doi.org/10.1017/cts.2022.118
work_keys_str_mv AT kerenskymax 216anexampleforestablishingaclinicallytranslationalinnovationlabatauniversitysetting
AT doloffjoshuac 216anexampleforestablishingaclinicallytranslationalinnovationlabatauniversitysetting
AT thakornitish 216anexampleforestablishingaclinicallytranslationalinnovationlabatauniversitysetting
AT theodorenicholas 216anexampleforestablishingaclinicallytranslationalinnovationlabatauniversitysetting
AT manbachiamir 216anexampleforestablishingaclinicallytranslationalinnovationlabatauniversitysetting